![](/img/cover-not-exists.png)
Cost-Effectiveness of Ribociclib Plus Letrozole Versus Palbociclib Plus Letrozole for Postmenopausal Women with Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER2–) Advanced/Metastatic Breast Cancer from A UK National Health Service Perspective
Hettle, R, Suri, G, Mistry, R, Chandiwana, D, Lee, AVolume:
20
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2017.08.202
Date:
October, 2017
File:
PDF, 60 KB
english, 2017